Fig. 4From: Lewy body disease as a potential negative outcome modifier of glioblastoma treatment: a case reportHematoxylin and eosin staining of the left temporal pole. Lymphocytes were seen in the brain parenchyma (A, scale bar = 100 μm). The Ki-67 proliferation index was low (B, scale bar = 50 μm) and there were observable atypical tumor nuclei (C, arrows, scale bar = 20 μm)Back to article page